
RETEVMO (Selpercatinib)
RETEVMO(TM) is a kinase inhibitor indicated for the treatment of: Adult patients with metastatic RET. fusion-positive non-small cell lung cancer (NSCLC) 1 (1.1) Adult and pediatric…
RETEVMO(TM) is a kinase inhibitor indicated for the treatment of: Adult patients with metastatic RET. fusion-positive non-small cell lung cancer (NSCLC) 1 (1.1) Adult and pediatric…
KOSELUGO is indicated for the treatment of pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN)…
WEGOVY is indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of [see Dosage…
OZEMPIC is indicated: as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies (14.1)]. to reduce the risk of major…
WEGOVY is indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of [see Dosage…
This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.
Privacy Policy | Copyright © 2022. All Rights Reserved.